Remco de Bree - Concepedia

Author

Remco de Bree

Amsterdam UMC Location Vrije Universiteit Amsterdam ORCID

Also Known As

Bree, R. de, Bree, Remco De, Frans J. M. Hilgers, R De Bree, R de Bree, R. Bree, R. DE BREE, R. De Bree, R. de Bree, Remco Bree

451

Publications

14.5K

Citations

H-Index

126

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam University Medical Center Utrecht The Netherlands Cancer Institute Vrije Universiteit Amsterdam University Medical Center Groningen

About

Remco de Bree is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	50	3.2K
2	Health Sciences	19	22	1.5K
3	Nursing	4	4	375
4	Arts	2	2	73
5	Engineering	2	2	108

Remco de Bree

151

Publications

8.8K

Citations

H-Index

Page 1

	Year	Citations
Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy Else Driehuis, Sigrid Kolders, Sacha Spelier, Cancer Discovery	2019	399
A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus Bernard M. Tijink, Jan Buter, Remco de Bree, Clinical Cancer Research	2006	310
Screening for Distant Metastases in Patients With Head and Neck Cancer Remco de Bree, Eline E. Deurloo, Gordon B. Snow, The Laryngoscope	2000	279
Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients Justin E. Swartz, Ajit J. Pothen, Inge Wegner, Oral Oncology Neck Cancer PatientsMedical ImagingMedicineHead And Neck CancerNeck Ct Imaging	2016	270
<scp>COVID</scp>‐19 pandemic: Effects and evidence‐based recommendations for otolaryngology and head and neck surgery practice Luiz Paulo Kowalski, Álvaro Sanabria, John A. Ridge, Head & Neck Novel Coronavirus DiseaseNeck Surgery PracticeEvidence‐based RecommendationsOtorhinolaryngologyHealth Care Workers	2020	270
Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial Geert O. Janssens, Saskia E. Rademakers, Chris H.J. Terhaard, Journal of Clinical Oncology	2012	251
Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer Anne W. Wendrich, Justin E. Swartz, Sandra I. Bril, Oral Oncology Chemotherapy Dose-limiting ToxicityNeck CancerPredictive FactorMedicinePathology	2017	225
Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial Anja van der Hout, Cornelia F. van Uden–Kraan, Karen Holtmaat, The Lancet Oncology NursingPatient ExperienceHealth-related QualityMedicineEhealth Application Oncokompas	2019	185
Radiation Dosimetry of <sup>89</sup>Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients Pontus K.E. Börjesson, Yvonne W. S. Jauw, Remco de Bree, Journal of Nuclear Medicine	2009	168
European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer Giulia Bertino, Gregor Serša, Francesca de Terlizzi, European Journal of Cancer Neck CancerEuropean ResearchMedicineSkin PharmacologyHead And Neck Cancer	2016	167

Page 1